Overview
Clinical Meaning
Scleroderma/Systemic Sclerosis involves specific alterations in scleroderma/systemic sclerosis physiology.
PMHNP
PMHNP
Scleroderma/Systemic Sclerosis involves specific alterations in scleroderma/systemic sclerosis physiology. The pathophysiology of Scleroderma/Systemic Sclerosis encompasses changes in myocardial contractility, cardiac conduction, vascular resistance, endothelial function, or structural integrity depending on the primary mechanism involved. Key cellular processes include ion channel dysfunction, inflammatory mediator activation, oxidative stress, fibrotic remodeling, and neurohormonal dysregulation that drive the clinical manifestations of scleroderma/systemic sclerosis.
Unlock full lesson + practice questions
4 more sections with scenarios, priorities, and review drills.
Final rapid review before practice
Next study step
Finish the lesson first, then choose a focused activity to apply what you just reviewed.
Continue studying
Sign in to save progress on this lesson.
Unlock the interactive lesson quiz with a plan that includes this PMHNP pathway. You can still explore topic-filtered questions from the bank hubs below.